Skip to main content

A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.

Publication ,  Journal Article
Bullard, DE; Thomas, DG; Darling, JL; Wikstrand, CJ; Diengdoh, JV; Barnard, RO; Bodmer, JG; Bigner, DD
Published in: Br J Cancer
February 1985

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Br J Cancer

DOI

ISSN

0007-0920

Publication Date

February 1985

Volume

51

Issue

2

Start / End Page

283 / 289

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • Middle Aged
  • Male
  • Immunotherapy
  • Humans
  • HLA Antigens
  • Glioma
  • Female
  • Combined Modality Therapy
  • Cell Line
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bullard, D. E., Thomas, D. G., Darling, J. L., Wikstrand, C. J., Diengdoh, J. V., Barnard, R. O., … Bigner, D. D. (1985). A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas. Br J Cancer, 51(2), 283–289. https://doi.org/10.1038/bjc.1985.41
Bullard, D. E., D. G. Thomas, J. L. Darling, C. J. Wikstrand, J. V. Diengdoh, R. O. Barnard, J. G. Bodmer, and D. D. Bigner. “A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.Br J Cancer 51, no. 2 (February 1985): 283–89. https://doi.org/10.1038/bjc.1985.41.
Bullard DE, Thomas DG, Darling JL, Wikstrand CJ, Diengdoh JV, Barnard RO, et al. A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas. Br J Cancer. 1985 Feb;51(2):283–9.
Bullard, D. E., et al. “A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.Br J Cancer, vol. 51, no. 2, Feb. 1985, pp. 283–89. Pubmed, doi:10.1038/bjc.1985.41.
Bullard DE, Thomas DG, Darling JL, Wikstrand CJ, Diengdoh JV, Barnard RO, Bodmer JG, Bigner DD. A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas. Br J Cancer. 1985 Feb;51(2):283–289.

Published In

Br J Cancer

DOI

ISSN

0007-0920

Publication Date

February 1985

Volume

51

Issue

2

Start / End Page

283 / 289

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • Middle Aged
  • Male
  • Immunotherapy
  • Humans
  • HLA Antigens
  • Glioma
  • Female
  • Combined Modality Therapy
  • Cell Line